Clinical Trial

Pharmacokinetic Study of DA-020

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
Pharmacokinetic Study of DA-020
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-02-07; most recent amendment 2026-04-08.
Trial Details
NCT Number NCT07402330
Lead Sponsor Applied Biology, Inc.
Collaborators: Daniel Alain, Inc., Follea International Limited
Conditions Chemotherapy Induced Alopecia, Chemotherapy Side Effects
Enrollment 60 participants
Start Date 2026-04-16
Primary Completion 2026-10-19 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-13